AXGN
Axogen Inc
43.40$
+0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.1% | -5.2% | +1.3% | +1.6% | +6.1% | -3.7% | +4.7% | +5.3% | +2.4% | +30.6% | +5.3% | |
| – | +0.6% | -10.6% | +4.6% | +4.9% | +15.0% | -6.2% | +11.1% | +10.7% | +5.2% | +53.4% | +8.5% | |
| – | -16.4% | -49.4% | +22.1% | -2.7% | +47.6% | -34.3% | +43.9% | -8.2% | +48.7% | +132.5% | +14.4% | |
| – | -19.6% | -43.2% | +19.8% | +16.1% | +36.5% | -34.1% | +62.8% | -0.4% | -0.7% | +132.5% | +14.4% | |
| – | +8.1% | -3.7% | +3.9% | -2.1% | -2.1% | +9.1% | +6.6% | +9.8% | -15.0% | +8.2% | +20.5% | |
| – | +0.0% | +20.1% | +1.4% | +4.8% | +13.0% | +7.0% | +3.6% | +10.4% | +4.4% | +8.7% | +2.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5.7% | +5.2% | +4.2% | +5.0% | +7.0% | +5.4% | +4.0% | +5.2% | +4.9% | +7.7% | +4.1% | |
| – | +4.5% | -7.7% | -0.1% | -0.7% | +7.8% | -9.0% | +2.6% | +2.6% | -2.9% | -51.9% | +8.8% | |
| – | +14.2% | -24.6% | +2.1% | -1.6% | +32.9% | -29.0% | +14.9% | +12.1% | -15.9% | +10.4% | +16.8% | |
| – | +41.1% | +6.3% | +6.5% | +6.0% | +6.1% | +6.0% | +5.9% | +5.7% | +1.5% | -10.8% | -6.6% | |
| – | -53.9% | +80.8% | +1.8% | -2.2% | -62.2% | +145.5% | +15.8% | +12.7% | -88.8% | +727.5% | +18.8% | |
| – | +0.5% | +0.5% | +0.5% | +0.5% | +0.5% | +0.5% | +0.5% | +0.5% | +0.5% | – | – | |
| – | -2.2% | -2.6% | +2.7% | +3.9% | +4.5% | +1.4% | +6.6% | +7.6% | +6.7% | +90.0% | +4.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.4% | +1.1% | +0.4% | +9.5% | -6.0% | +0.9% | +0.7% | +2.2% | +9.9% | +3.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.